Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

Treatment for Early Memory Loss

NCT00042172 ·Status: COMPLETED ·Phase: PHASE4

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

NCT01327859 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

NCT00827034 ·Status: COMPLETED ·Phase: PHASE1

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

NCT00711204 ·Status: WITHDRAWN ·Phase: PHASE4

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil

NCT02822573 ·Status: COMPLETED ·Phase: PHASE3

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

NCT01066546 ·Status: TERMINATED ·Phase: PHASE3

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

NCT00954590 ·Status: TERMINATED ·Phase: PHASE3

Drug-Drug Interaction Study With Aricept® (Donepezil)

NCT01042314 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

NCT00096473 ·Status: COMPLETED ·Phase: PHASE3

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

NCT00478205 ·Status: COMPLETED ·Phase: PHASE3

Donepezil to Treat Dementia in Parkinson's Disease

NCT00030979 ·Status: COMPLETED ·Phase: PHASE4

Memory Impairment Study (Mild Cognitive Impairment Study)

NCT00000173 ·Status: COMPLETED ·Phase: PHASE3

Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

NCT01082965 ·Status: TERMINATED ·Phase: NA

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

NCT00934375 ·Status: COMPLETED ·Phase: PHASE4

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

NCT03316898 ·Status: WITHDRAWN ·Phase: PHASE1

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

NCT00842816 ·Status: COMPLETED ·Phase: PHASE2

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

NCT02262975 ·Status: COMPLETED

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

NCT00483028 ·Status: COMPLETED ·Phase: NA

A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease

NCT03197740 ·Status: COMPLETED ·Phase: PHASE3

Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)

NCT01181310 ·Status: COMPLETED ·Phase: PHASE1

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

NCT00369603 ·Status: TERMINATED ·Phase: PHASE4

A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®

NCT02968719 ·Status: COMPLETED ·Phase: PHASE1

Corticolimbic Degeneration and Treatment of Dementia

NCT00768261 ·Status: COMPLETED ·Phase: PHASE4

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

NCT00708552 ·Status: COMPLETED ·Phase: PHASE2

Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

NCT00384423 ·Status: COMPLETED ·Phase: PHASE2